Sodium Oxybate in the Management of Narcolepsy: One Molecule, Three Formulations and the Critical Role of Shared Decision-Making in Its Use
Host: Clete A. Kushida, MD, PhD
\n\n Guest: Michael J. Thorpy, MD
\n\n\n \n
Three different sodium oxybate formulations are available for the management of narcolepsy with/without cataplexy. While they are equally efficacious, there are differences such as dosing that require shared decision- making between patient and clinician to select the right formulation for each patient. Join Drs. Kushida and Thorpy as they share their approach to making the right treatment decision for each patient, one that includes ensuring patient preferences are considered.